Mucin glycoproteins in human gallbladder carcinoma and their biological effects on tumor invasion and metastasis capability.

人胆囊癌中的粘蛋白糖蛋白及其对肿瘤侵袭和转移能力的生物学作用。

基本信息

  • 批准号:
    13671279
  • 负责人:
  • 金额:
    $ 2.5万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2003
  • 项目状态:
    已结题

项目摘要

The overall prognosis of gallbladder carcinoma is poor because of a high percentage of advanced cases at the time of operation and thereby a lower curability. pT2 carcinoma is limited in the gallbladder wall, and therefore a high curability as well as a better prognosis can be expected. However, the prognosis has not been necessarily good since distant recurrences are found in some cases of pT2 carcinomas. Alterations in glycosilation of mucins, such as an alteration in the site of O-glycosylation of mucin core proteins or an enhanced sialylation of carbohydrate structures, are known in the process of malignant transformation.Sialylated MUC1 recognized by a mAb MY.1E12 (Jpn J Cancer Res 1996;87:488-496) has been used as a marker for invasive adenocarcinomas. In pT2 gallbladder carcinoma, the high level expression of stromal localization of sialylated MY.1E12-reactive-MUC1 at the invading sites correlates with the aggressiveness of the disease, such as the tendency to form distant metastasis.Thus, alterations in carbohydrate chains of carcinoma-producing mucin glycoproteins potentiate the capability of tumor invasion and/or metastasis.
胆囊癌的整体预后较差,因为手术时晚期病例的比例很高,因此治愈率较低。pT 2癌局限于胆囊壁,因此可以预期高治愈率以及更好的预后。然而,预后并不一定好,因为在一些pT 2癌病例中发现远处复发。在恶性转化过程中,已知粘蛋白的糖基化的改变,例如粘蛋白核心蛋白的O-糖基化位点的改变或碳水化合物结构的唾液酸化增强。由mAb MY.1E12识别的唾液酸化MUC 1(Jpn J Cancer Res 1996;87:488-496)已被用作侵袭性腺癌的标志物。在pT 2胆囊癌中,浸润部位的唾液酸化MY.1E12-reactive-MUC 1的间质定位的高水平表达与疾病的侵袭性相关,例如形成远处转移的倾向。因此,产生癌的粘蛋白糖蛋白的糖链的改变增强了肿瘤侵袭和/或转移的能力。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Patterns and predictors of failure after curative resections
根治性切除术后失败的模式和预测因素
Expression of cyclooxygenase-2 in the subserosal layer.
浆膜下层中环氧合酶 2 的表达。
Toru Kawamoto: "Expression of Cyclooxygenase-2 in the Subserosal Layer Correlates with Postsurgical Prognosis of PT2 Carcinoma of the Gallbladder"International Journal of Cancer. (in press). (2002)
Toru Kawamoto:“浆膜下层环氧合酶 2 的表达与 PT2 胆囊癌的术后预后相关”《国际癌症杂志》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Expression of MUC1 mucins in the subserosal layer
浆膜下层MUC1粘蛋白的表达
  • DOI:
  • 发表时间:
    2001
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kawamoto T et al.
  • 通讯作者:
    Kawamoto T et al.
Toru Kawamoto: "Expression of MUC 1 Mucins in Subserosal Layer Correlates with Postsurgical Prognosis of PT2 Carcinoma of the Gallbladder"Clinical Cancer Research. Vol.7. 1333-1342 (2001)
Toru Kawamoto:“浆膜下层 MUC 1 粘蛋白的表达与 PT2 胆囊癌的术后预后相关”临床癌症研究。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TODOROKI Takeshi其他文献

TODOROKI Takeshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TODOROKI Takeshi', 18)}}的其他基金

Protection of hepatic microcirculatory disturbance due to the ischemia-reperfusion injury
对缺血再灌注损伤引起的肝脏微循环障碍的保护作用
  • 批准号:
    13671278
  • 财政年份:
    2001
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The effect of TAK-O44 combined with SOD-DIVEMA on ischemia reperfusion liver injury.
TAK-O44联合SOD-DIVEMA对缺血再灌注肝损伤的影响
  • 批准号:
    11671208
  • 财政年份:
    1999
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
SDUDIES OF HIGH MOLECULAR SUBSTANCE- SOD CONJUGATE ON PREVENSION OF HEPATIC ISCHEMLA-REPERFUSION INJURY AND HEPATIC MICROCIRCULATION
高分子物质-SOD结合物预防肝缺血再灌注损伤及肝微循环的研究
  • 批准号:
    08671410
  • 财政年份:
    1996
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Prevention of reperfusion liver injury by SOD-(DIVEMA) conjugate
SOD-(DIVEMA) 结合物预防再灌注肝损伤
  • 批准号:
    06455003
  • 财政年份:
    1994
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了